📖
Prognostic Significance of Response Dynamics in Atezolizumab plus Bevacizumab-Treated Hepatocellular Carcinoma: A Multicenter Real-World Validation Study.
Guan R, Huang K, Zheng Z, Zhao Z, Tang M, Jin H, Mei J, Lin Y

Prognostic Significance of Response Dynamics in Atezolizumab plus Bevacizumab-Treated Hepatocellular Carcinoma: A Multicenter Real-World Validation Study.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Liver Cancer.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Prognostic Significance of Response Dynamics in Atezolizumab plus Bevacizumab-Treated Hepatocellular Carcinoma: A Multicenter Real-World Validation Study.
Author / Organization Guan R, Huang K, Zheng Z, Zhao Z, Tang M, Jin H, Mei J, Lin Y
Subject & Discipline Liver Cancer
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-50071
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »